Lv1
4 积分 2024-11-03 加入
HER2-targeted therapies in gastric cancer
1小时前
已完结
Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
1天前
已完结
Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer
1天前
已完结
Breast cancer
10天前
已完结
皖公网安备34019202002308
